MedTrace Logo

Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone

NCT03484260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27778

Last updated 2019-05-14

No results posted yet for this study

Summary

We will investigate if testosterone is preferentially given to patients at higher risk of cardiovascular events. If this is the case, then observational studies may be prone to selection bias resulting in overestimation of the cardiovascular risk associated with testosterone when compared to a healthier population not taking testosterone

Conditions

  • Hypogonadism

Interventions

DRUG

Testosterone Product

Men used testosterone product following prescription

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-05-15
Completion
2018-05-15

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03484260 on ClinicalTrials.gov